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Abstract The bacterial spectrum in chronic rhinosinusitis
(CRS) is clinically relevant. This study aimed to compare
two sampling techniques and to characterise Staphylococ-
cus aureus isolated from CRS patients. Bacterial specimens
were collected from the nares and maxillary sinus in 42
CRS patients and from the nares in 57 healthy controls.
Maxillary sinus sampling was performed in two ways in
each patient: with a cotton-tipped aluminium swab through
the enlarged sinus ostium, and with a protected brush. S.
aureus was characterised by DNA-sequencing of the repeat
region of the S. aureus protein A gene, spa typing. The
protected brush technique was superior to the cotton-tipped
aluminium swab in reducing contamination rate. However,
the two sampling methods were consistent in terms of
clinically relevant bacterial findings, and the easy-to-han-
dle cotton-tipped swab can still be recommended when
culturing the maxillary sinus. Patients showed a signifi-
cantly higher presence of S. aureus in the nares compared
with healthy controls, and healthy controls showed a sig-
nificantly higher presence of coagulase-negative staphylo-
cocci in the nares compared with patients. The spa types
were identical for the nares and maxillary sinus in all
patients except one. The sampling techniques showed
equivalent results, indicating a low risk of unnecessary
antibiotic treatment when using the easy-to-handle cotton-
tipped aluminium swab. The high rate of identical spa
types of S. aureus isolated from the nares and maxillary
sinus of CRS patients might indicate colonisation of the
maxillary sinus from the nares.
Keywords Staphylococcus aureus  Sinusitis  Nasal
polyps  Sampling studies  Bacterial typing
Introduction
Chronic rhinosinusitis (CRS) affects more than 10 % of the
European population [1]. The condition is characterised by
nasal congestion, nasal discharge, headache, facial fullness,
and changes in smell and taste lasting longer than 3 months,
and is verified by nasal endoscopy and/or computerised
tomography of the sinuses [2, 3]. The disease is probably
multifactorial, and different factors have been suggested to
affect its development, including environmental factors and
host factors [4–7]. Reduced ventilation of the sinuses due to
blockage of the ostiomeatal complex in the middle nasal
meatus is thought to be one factor [6, 8]. Reduced oxygen
pressure in the sinus and absorption of oxygen might pro-
mote bacterial growth [9]. Allergy and asthma are suggested
to enhance mucosal swelling and cause obstruction of the
ostium, thereby predisposing for CRS. Immune deficiencies,
cell membrane sodium and chloride channel malfunction,
and ciliary dysfunctionmay also be contributing factors [10].
Important environmental factors in development of CRS are
probably microbial, especially fungi and bacteria con-
tributing to chronic mucosal inflammation [7]. Bacterial
biofilms are often found in sinuses in patients with CRS
undergoing sinus surgery and are associated with more
severe disease [11, 12]. Biofilms are complex structures
composed of communities of microbs embedded within an
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extracellular matrix, predominantly polysaccharides. Bac-
terial involvement is well accepted in the pathogenesis of
acute sinusitis, where Streptococcus pneumoniae, Hae-
mophilus influenzae, andMoraxella catarrhalis are the most
common bacterial findings [5, 13]. The role of bacteria in
CRS is less clear, and findings of Staphylococcus aureus,
coagulase-negative staphylococci (CoNS), and anaerobes
seem to dominate to various extents in different studies
[13–19]. However, a Brazilian study of 62 samples from
maxillary sinuses of CRS patients found no anaerobes, and
Pseudomonas aeruginosa was the most commonly found
bacterium [20]. The variability in microbial presence in
different studies might be a result of differences in culturing
techniques, contamination of samples, patient selection,
ethnic origin of the patients, and pre-treatment regimens. In
addition, handling of samples can affect growth due to the
high sensitivity of the anaerobes. S. aureus inmaxillary sinus
cultures has been reported in about 25 % of patients with
CRS [21]. A meta-analysis supports the role of S. aureus in
asthma and allergic rhinitis [22], and S. aureus has also been
shown to have an association with inflammatory diseases,
such as atopic dermatitis [23, 24]. S. aureus displays a wide
range of virulence factors; among these, staphylococcal
enterotoxins and toxic shock syndrome toxin-1 have been
demonstrated to activate the immune system and affect
proinflammatory cells by acting as superantigens. Some
studies have suggested that chronic rhinosinusitis with nasal
polyposis (CRSwNP) has a relationship with S. aureus
infection and especially with staphylococcal enterotoxins as
a modulator of the disease [6, 25–27]. The aim of this study
was to investigate the bacterial spectrum patients with CRS,
and especially the presence of S. aureus, and to characterise
S. aureus isolated from the nares and maxillary sinus of CRS
patients in comparison with samples from the nares in
healthy controls. Another aim was to evaluate an optimised
culturing technique for the maxillary sinus.
Materials and methods
Patients and controls
Forty-two patients with CRS were recruited at the
Department of Otolaryngology, O¨rebro University Hospi-
tal, Sweden, from 2004 to 2010. Two ENT specialists (UT
and SH) were responsible for the inclusion procedure. The
diagnosis of CRS was based on history, clinical examina-
tion, and computed tomography scans according to the
definitions and guidelines of the American Academy of
Otolaryngology—Head and Neck Surgery [2]. A position
paper on rhinosinusitis guidelines [28], prepared by the
European Academy of Allergology and Clinical
Immunology and approved by the European Rhinologic
Society, [3] was published after the inclusion procedure for
this study had started. However, the definition of this
position paper matches that used in this study. Patients
visiting the ENT outpatient clinic with CRS and an
enlarged opening to the maxillary sinus due to previous
surgery, and patients with CRS admitted for sinus surgery,
were invited to participate. Nasal endoscopy was per-
formed, and the presence or absence of nasal polyps was
documented; thus, patients were identified as having either
chronic rhinosinusitis without nasal polyposis (CRSsNP) or
with nasal polyposis (CRSwNP). The inclusion procedure
was not consecutive. Healthy volunteers were invited to
participate in the study when visiting the O¨rebro travel
consultation clinic. Fifty-seven controls were enrolled, and
all of them did declare ‘‘no nasal polyps as an adult’’ and
‘‘no previous sinus surgery’’. All participants were
[18 years. There was 17/42 (40.5 %) male in the study
group and 26/57 (45.6 %) male in the control group. The
mean age was 52.5 years in the patient group and
50.0 years in the control group. Additional informed con-
sent was obtained from all individual participants from
whom identifying information is included in this study.
Samples
Specimens were collected from the nares and maxillary
sinuses of the patients, and from the nares of the healthy
controls. Sampling from the maxillary sinuses of CRS
patients was performed with an endoscope, using a cotton-
tipped aluminium swab (Copan, Brescia, Italy) passing the
nasal cavity and placed into the sinus through the enlarged
sinus ostium under visual control (Fig. 1). Care was taken
to avoid contamination via contact with the nose wall.
Fig. 1 Cotton-tipped aluminium swab (Copan, Brescia, Italy)
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Samples were also taken from the maxillary sinuses of
patients with a protected brush (Olympus, model no BC-
202D-3010), which could be shielded with a cover when
passing through the narrow space such as the nasal cavity.
This brush is often used when collecting bronchial speci-
men (Fig. 2). The brush was used thought an enlarged sinus
ostium. Nasal specimens were collected from patients and
controls using a nasal swab touching the nares. The criteria
for a concordance between the two different sampling
methods were defined as equal bacterial findings regarding
both type and number of bacterial species.
Microbiological analysis
The culture and species verification of bacteria was per-
formed in accordance with routine diagnostic procedures at
the Department of Laboratory Medicine, Clinical Microbi-
ology, O¨rebro University Hospital. Samples were cultured
on blood agar medium [4.25 % Columbia II Agar (BBL,
Becton–Dickinson, Baltimore,MD,USA), 0.3 %AgarNo. 2
(Lab M Ltd., Bury, UK), and 5 % bovine blood] in an
anaerobic atmosphere on FAA plates (4.6 % LAB 90 Fas-
tidious Anaerobe Agar, LAB M, Lancashire, UK) supple-
mented with 5 % horse blood and incubated for 2 days at
37 C. S. aureus isolates were dissolved in preservation
medium [yeast extract (DIFCO Laboratories, Sparks, MD,
USA) and horse serum added trypticase soy broth (BBL,
Sparks, MD, USA)] and stored at -70 C pending further
spa typing that was performed as previously described [29].
Spa typing
Single locus DNA-sequencing of the repeat region of the
Staphylococcus protein A gene (spa) for typing of S. aureus
was performed as previously described [30].
Statistics
Fisher’s exact test was used to calculate p values reflecting
the difference between groups containing categorical data,
and the Chi-squared test was used for the same purpose
with quantitative data. A p value \0.05 was considered
statistically significant.
Results
Initial enrolment comprised 43 patients with CRS and 58
healthy controls. One patient was excluded due to having
titanic dental implants reaching the maxillary sinus, and
one of the controls was excluded due to an age below
18 years. The study group therefore consisted of 42
patients and 57 controls. Mean age was almost equal
between the groups (51.5 and 50.0 years). The patient
group was 46.0 % male, and the control group was 40.5 %
male. Polyposis was present in 24 of the 42 (57 %) patients
and none of the controls. All samples collected from the
nares showed bacterial growth, though one sample in the
patient group was missing. Fourteen different bacteria were
identified. Table 1 shows the bacterial findings in patients
and controls. The most common aerobic bacteria were
CoNS, isolated from the maxillary sinus in 18/42 (43 %)
patients. CoNS was found in nares in 17/42 (40 %)
patients, and in 43/57 (75 %) controls (p = 0.0008). S.
aureus was found in both nares and maxillary sinus in
15/42 (36 %) patients using the protected brush technique
and in 18/42 (43 %) patients using the cotton-tipped alu-
minium swab technique (p = 0.66). S. aureus was isolated
in the nares in 24/42 (57 %) patients and 16/57 (28 %)
controls (p = 0.004). S. aureus findings in the maxillary
sinus did not differ significantly between CRSwNP patients
and CRSsNP patients (p = 0.35). Facultative anaerobic
bacteria were found in five samples from nares of CRS
patients and in two samples from controls. There was no
significant difference between the patients and controls
regarding the presence of facultative anaerobic bacteria in
nares (p = 0.13). Maxillary sinus cultures using the pro-
tected brush technique showed two species present in 6/42
(14.3 %) patients, but none with three or more, while
cultures using the conventional technique showed mixed
flora in 14/42 (33 %) patients. At least one species of
aerobic bacteria was cultured from 41/42 (98 %) patients,
and anaerobic/facultative anaerobic bacteria was cultured
from the maxillary sinus in 5/42 (12 %) patients. The nares
showed mixed flora in 7/57 (12 %) controls and 14/42
(33 %) patients. Three samples (7 %) showed no growth,
all collected with the brush technique from the maxillary
sinus in CRS patients. In a comparison between the two
sampling techniques, there was consistency in growth in
Fig. 2 Protected brush (Olympus, model no BC-202D-3010)
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23/42 (56 %) patients. In 22/42 (52 %) of the brush sam-
ples, there was growth of only one species (Table 2). In
one case, S. pneumoniae was found with the cotton-tipped
aluminium swab and H. influenzae with the protected
brush, and in another case, S. aureus was found with the
cotton-tipped aluminium swab and H. influenzae with the
protected brush. Furthermore, in two cases, a-streptococci
and anaerobic Gram-positive cocci, respectively, were
found with the protected brush but not with the cotton-
tipped aluminium swab.
There was a wide variation in the distribution of spa
types (Table 3; Fig. 3). We found identical spa types of S.
aureus from the nares and from the maxillary sinus in
17/18 patients (94 %). The remaining patient with S. aur-
eus isolates showed two unrelated spa types in the two
areas: t084 and t189.
Discussion
The isolation rate of S. aureus in maxillary sinus cultures
from patients with CRS has been reported to be about 25 %
[21]. In this study, S. aureus was found in 15/42 (36 %) of
the maxillary sinus cultures from CRS patients with both
the optimised sampling technique (protected brush) and
standard cotton-tipped aluminium swab. In another three
patients, S. aureus were found using standard cotton-tipped
aluminium swab but not with the brush. This indicates a
contamination rate of 3/18 (17 %) for S. aureus. In 17/42
(40.5 %) samples, bacterial findings with standard cotton-
tipped aluminium swab differ from findings using protected
brush. However, CoNS in combination with other bacterial
findings using cotton-tipped aluminium swab compromised
most of these differences. The protected brush technique
was superior to the standard cotton-tipped aluminium swab
in reducing the contamination of CoNS and S. aureus when
culturing maxillary sinus. However, the clinical relevance
of using this optimised technique as the protected brush is
questionable. In almost all patients cultured with the cot-
ton-tipped aluminium swab, this culturing technique
seemed to be adequate for collecting clinically relevant
samples, and thus have a low impact on antibiotic treat-
ment (Table 3). S. aureus is thought to persistently colo-
nise the nares of about 20 % of the population (range
12–30 %), and approximately 30 % of the remainder is
intermittent carriers (range 16–70 %) [31, 32]. Wertheim
Table 1 Frequency of bacterial findings in samples from patients with chronic rhinosinusitis with nasal polyposis (CRSwNP), chronic rhi-
nosinusitis without nasal polyposis (CRSsNP), and healthy controls














Controls (n = 57)
Aerobic bacteria
CoNS** 9 (38 %) 9 (50 %) 18 (43 %) 10 (42 %) 7 (39 %) 17 (40 %) 43 (75 %)
Staphylococcus aureus 8 (33 %) 7 (39 %) 15 (36 %) 14 (58 %) 10 (56 %) 24 (57 %) 16 (28 %)
Haemophilus influenzae 2 (8 %) 1 (5.6 %) 3 (7.1 %) 0 1 (2 %)
Diphtheroid rods 2 (8 %) 2 (4.7 %) 2 (8 %) 2 (11 %) 4 (9.5 %) 4 (7 %)
Pseudomonas sp 0 1 (5.6 %) 1 (2.3 %) 0
Moraxella sp 0 1 (4 %) 1 (2.3 %) 0
a-haemolytic streptococci 1 (4 %) 1 (2.3 %) 1 (4 %) 1 (5.6 %) 2 (4.7 %) 1 (2 %)
Staphylococcus
lugdunensis
1 (4 %) 1 (2.3 %) 0 0
Micrococcus sp 0 0 1 (2 %)
Streptococcus
pneumoniae
1 (4 %) 1 (2.3 %) 2 (8 %) 2 (4.7 %) 0
Enterobacteriaceae*** 2 (8 %) 2 (4.7 %) 3 (12.5 %) 1 (5.6 %) 4 (9.5) 1 (2 %)
Escherichia coli 0 1 (4 %) 1 (2.3 %) 1 (2 %)
Anaerobic
Propionibacterium acnes 1 (4 %) 1 (2.3 %) 0 0
Anaerobic Gram-positive
cocci
1 (4 %) 1 (2.3 %) 0 0
* One culture is missing
** Coagulase-negative staphylococci (CoNS)
*** Except Escherichia coli
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Table 2 Comparison of two different sampling techniques used in 42 patients with chronic rhinosinusitis (CRS)




Concordance* Assumed impact on the optimal
choice of antibiotics treatment
when based on findings
with rayon wire swab
1 Streptococcus pneumoniae Haemophilus influenzae – High
2 Staphylococcus aureus
CoNS**
Staphylococcus aureus – Low
3 CoNS
Diphtheroid rods
Diphtheroid rods – Low
4 Staphylococcus aureus Staphylococcus aureus ? Low




Streptococcus pneumoniae – Low
7 Staphylococcus aureus
Propionibacterium acnes
Staphylococcus aureus – Low
8 CoNS CoNS ? Low
9 CoNS CoNS ? Low
10 Staphylococcus aureus Staphylococcus aureus
CoNS
– Low
11 Staphylococcus aureus Haemophilus influenzae – Highs
12 Staphylococcus aureus Staphylococcus aureus
CoNS
– Low
13 CoNS CoNS ? Low
14 Staphylococcus aureus Staphylococcus aureus ? Low
15 CoNS CoNS ? Low
16 CoNS CoNS ? Low




Haemophilus influenzae – Low
19 CoNS CoNS ? Low







23 Staphylococcus aureus Staphylococcus aureus ? Low
24 CoNS CoNS ? Low
25 Staphylococcus lugdunensis Staphylococcus lugdunensis ? Low
26 Staphylococcus aureus Staphylococcus aureus ? Low




29 CoNS CoNS ? Low
30 Staphylococcus aureus Staphylococcus aureus ? Low
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et al. regarded the nose as the major site of S. aureus
carriage, and from here, the organism is thought to spread
to other parts of the body [32]. S. aureus and CoNS were
the predominant bacterial findings in the maxillary sinus of
our patients with CRS. In addition, the number of patients
with CRS with S. aureus in the nares was statistically
significantly higher than the number of controls with S.
aureus in the nares, while the number of patients with
CoNS was statistically significantly lower compared to
controls. The high S. aureus colonisation rate of the nares
in patients with CRS may reflect its importance in the CRS
disease. A hypothesis based on our findings might be that
S. aureus counteracts the CoNS in the nares and promotes
colonisation of S. aureus in the maxillary sinus through
transport of bacteria across the mucus conjoining the nares
with the sinus.
Furthermore, identical spa types in both the nares and
maxillary sinus were found in all patients with findings of
S. aureus in both locations (with one exception), which
supports the theory that the nares can be the primary site
from where the bacteria can spread and colonise the
maxillary sinus. S. aureus has in certain circumstances the
ability to produce enterotoxins acting as superantigens that
bind to T cells and exaggerate disease severity and
expression [25], and cause serious invasive diseases such
as sepsis with or without infective endocarditis and
necrotising pneumonia as well as mild diseases, such as
superficial skin and soft tissue infections. S. aureus
enterotoxins may play a role in the severity of CRS,
especially CRSwNP [27, 33, 34]. The ability of super-
antigens to enhance inflammatory reactions [25] might
have a connection to the predominance of S. aureus in
CRS, again especially CRSwNP [35]. An increased
immune response to S. aureus enterotoxins has been
demonstrated in nasal polyposis tissue, resulting in more
pronounced eosinophilic inflammation and higher local
immunoglobulin E production against staphylococcal
enterotoxins in patients affected by CRSwNP [26, 36]. Our
study included 23 patients with CRSwNP and 19 with
CRSsNP. We could not find any differences in bacterial
findings in nares or maxillary sinus when comparing these
groups, but the two groups were small and comparison is
difficult. Brook et al., who studied the microbiology of the
maxillary sinus in 48 patients with CRS, also found no
difference between CRSwNP and CRSsNP [37] which
recently also was shown by Brook et al. [38]. Another
study showed no significant difference in the prevalence of
genes encoding virulence factors between isolates from
patients with CRS and healthy controls [39]. However, a
large meta-analysis by Ou et al. based on 12 case–control
studies with a total of 340 cases and 178 controls demon-
strated a relationship between the presence of S. aureus
superantigens and the persistence and severity of CRSwNP
[27].
Table 2 continued




Concordance* Assumed impact on the optimal
choice of antibiotics treatment
when based on findings
with rayon wire swab
33 CoNS CoNS ? Low
34 CoNS CoNS ? Low
35 Staphylococcus aureus Staphylococcus aureus ? Low
36 Staphylococcus aureus Staphylococcus aureus ? Low
37 Escherichia coli Propionibacterium acnes – Highs


















Specimens obtained from the maxillary sinus
* Concordance meaning that the same type of bacteria was found with both culturing technique
** Coagulase-negative staphylococci (CoNS)
316 Eur Arch Otorhinolaryngol (2017) 274:311–319
123
The high rate of S. aureus in the maxillary sinus in
patients with CRS in our study strengthens the importance
of S. aureus for the pathogenesis of the disease, but its role
needs to be further investigated. Larger studies could
hopefully lead to valuable knowledge about the role of S.
aureus in CRS. Sweden is a low endemic area for methi-
cillin-resistant S. aureus (MRSA), and there was only one
MRSA isolate in our study; this is probably also due to a
generally low prescription of antibiotics in Sweden, which
leads to low incidence of resistant isolates. All participants
were living in Sweden, but we have no information on
ethnic origin, which may have been of interest. Some
patients were included in conjunction with sinus surgery,
and some had a previous history of sinus surgery and were
included as outpatients at the otolaryngology clinic.
However, a previous study indicates that endoscopic sinus
surgery does not change the bacterial flora, though it does
change the presence of bacterial biofilms in the sinus [40].
Conclusion
Contamination with CoNS was common using cotton-tip-
ped aluminium swab technique. However, the protected
brush technique did reduce the contamination rate but does
not significantly improve the reliability of bacteriological
diagnostics for practical clinical use. The risk of unneces-
sary antibiotic treatment is, therefore, thought to be low
when using the easy-to-handle cotton-tipped aluminium
swab. Furthermore, S. aureus was found in 36 % of the
maxillary sinus samples from the CRS patients, and the
number of patients with S. aureus in the nares was statis-
tically significantly higher than the number of controls with
Fig. 3 Distribution and genetic relationship of spa types of S. aureus
isolates from the nares in controls (grey) and CRS patients (black).
One circle represents one isolate
Table 3 Distribution of spa
types of S. aureus isolates from
patients with chronic
rhinosinusitis (CRS) in both
maxillary sinus and nares
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S. aureus in the nares, while the number of patients with
CoNS in the nares was statistically significantly lower
compared to controls. These findings, together with a very
high rate of identical spa types of S. aureus from patients
with S. aureus in both nares and maxillary sinus, might
indicate colonisation of the maxillary sinus from the nares
and presumably a relationship between S. aureus and CRS.
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